Marucci Anthony S 4
4 · Celldex Therapeutics, Inc. · Filed Aug 9, 2021
Insider Transaction Report
Form 4
Marucci Anthony S
President & CEO
Transactions
- Exercise/Conversion
Common Stock
2021-08-05$42.00/sh+3,537$148,554→ 27,231 total - Exercise/Conversion
Incentive Stock Option
2021-08-05−3,537→ 0 totalExercise: $42.00Exp: 2021-08-05→ Common Stock (3,537 underlying)
Footnotes (3)
- [F1]Includes 4,256 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Option Plan. On February 8, 2019, Celldex Therapeutics, Inc. effected a 1-for-15 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
- [F2]This option was previously reported as covering 180,400 shares at an exercise price of $2.80 per share, but has been adjusted to reflect the Reverse Stock Split. The remaining 8,488 shares of common stock underlying the option expired on August 5, 2021.
- [F3]As of August 5, 2015, the option is fully vested.